Omron Strengthens AI-Powered Remote ECG Diagnosis Push in India with Tricog

Omron’s integrated systems aim to reduce that window further in certain settings, while Tricog reports turnaround times of about six minutes for standard readings.

Omron, a Japanese medtech company, has intensified its push into AI-powered remote ECG diagnosis in India, partnering with Singapore-based Tricog Health, enabling rapid cardiac assessments in as little as 10 seconds across homes and clinics.

Industry estimates suggest that over 100 million people currently live with heart conditions, and that number is projected to rise sharply in the coming decades. At the same time, access to cardiologists and trained ECG interpreters remains uneven, particularly outside major cities.

This gap has slowed widespread ECG adoption compared to advanced healthcare systems, despite growing awareness of arrhythmias such as atrial fibrillation, which can trigger stroke or heart failure if undetected.

Omron, through its subsidiary Omron Healthcare, first invested in Tricog Health India in 2023. A pilot for home-based patient recovery monitoring began in 2025, with broader rollout to clinics and households planned in fiscal 2026.

Tricog, founded in 2014, now supports ECG interpretation services for roughly 12,000 hospitals in India. Its AI tool analyzes ECG waveforms and is backed by more than 100 specialist physicians who review cases when needed.

Tricog reports turnaround times of about six minutes for standard readings, while Omron’s integrated systems aim to reduce that window further in certain settings.

Omron’s devices categorize atrial fibrillation and related risks into six levels, helping primary care physicians determine whether further hospital evaluation is necessary. When used at home, AI-generated findings are reviewed by Tricog physicians to reinforce diagnostic confidence.

The model is designed to support non-specialist clinicians, enabling earlier intervention and potentially reducing avoidable complications.

The India expansion forms part of Omron’s broader global ECG strategy under its “Going for ZERO” vision. As Ayumu Okada, President and CEO, OMRON Healthcare, said, "Confronting the heart failure 'pandemic' and the shortage of cardiovascular specialists requires new approaches. By combining innovative technology with strategic partnerships, we aim to take our cardiovascular business to the next stage and help prevent serious cardiac events before they occur."

The company has also announced additional investment in Tricog and plans to acquire the Heartnote ECG service business from JSR Corporation in Japan. Heartnote’s wearable Holter patch records cardiac activity for up to seven days, aiming to detect intermittent arrhythmias while reducing patient discomfort.

Stay tuned for more such updates on Digital Health News